Citrine Global Corp
SkyTech Orion Global Corp. operates as a plant-based wellness and pharma solutions company in Israel. It focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, treatments, or an unbalanced lifestyle. The company's products include sprays, powders, tablets, capsules, and tinctures. The company offers … Read more
Citrine Global Corp (CTGL) - Net Assets
Latest net assets as of September 2025: $-3.88 Million USD
Based on the latest financial reports, Citrine Global Corp (CTGL) has net assets worth $-3.88 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.34 Million) and total liabilities ($5.22 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.88 Million |
| % of Total Assets | -288.33% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -2464.91% |
| Growth Volatility | 251.94 |
Citrine Global Corp - Net Assets Trend (2010–2025)
This chart illustrates how Citrine Global Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Citrine Global Corp (2010–2025)
The table below shows the annual net assets of Citrine Global Corp from 2010 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-2.69 Million | 0.00% |
| 2024-12-31 | $-2.69 Million | -8.89% |
| 2023-12-31 | $-2.48 Million | -0.16% |
| 2022-12-31 | $-2.47 Million | -71.60% |
| 2021-12-31 | $-1.44 Million | -202.65% |
| 2020-12-31 | $1.40 Million | +441.52% |
| 2019-12-31 | $-410.76K | -155.40% |
| 2018-12-31 | $741.45K | +44.98% |
| 2017-12-31 | $511.43K | +348.79% |
| 2016-12-31 | $113.96K | -89.21% |
| 2015-12-31 | $1.06 Million | -24.33% |
| 2014-12-31 | $1.40 Million | +186.38% |
| 2013-12-31 | $487.55K | +678.66% |
| 2012-12-31 | $62.61K | +95.15% |
| 2011-12-31 | $32.09K | -48.81% |
| 2010-12-31 | $62.68K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Citrine Global Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3180500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $104.00K | % |
| Other Comprehensive Income | $117.00K | % |
| Other Components | $28.89 Million | % |
| Total Equity | $-2.69 Million | 100.00% |
Citrine Global Corp Competitors by Market Cap
The table below lists competitors of Citrine Global Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Korean Reinsurance Co. Ltd.
KQ:003690
|
$82.01K |
|
TonnerOne World Holdings Inc
PINK:TONR
|
$82.01K |
|
CITIZEN HOLDINGS - Dusseldorf Stock Exchang
DU:CTZ
|
$82.02K |
|
ANTA SPORTS PRODUCT (AS7.SG)
STU:AS7
|
$82.04K |
|
CITIZEN HOLDINGS (CTZ.SG)
STU:CTZ
|
$81.96K |
|
179720
KO:179720
|
$81.92K |
|
Boostheat
PA:ALBOO
|
$81.90K |
|
VANDA PHARMA (VM4.SG)
STU:VM4
|
$81.90K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Citrine Global Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -2,695,000 to -2,695,000, a change of 0.
- Net loss of 2,298,000 reduced equity.
- Other comprehensive income increased equity by 117,000.
- Other factors increased equity by 2,181,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-2.30 Million | -85.27% |
| Other Comprehensive Income | $117.00K | +4.34% |
| Other Changes | $2.18 Million | +80.93% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Citrine Global Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | $0.05 | $0.00 | x |
| 2011-12-31 | $0.02 | $0.00 | x |
| 2012-12-31 | $0.04 | $0.00 | x |
| 2013-12-31 | $0.24 | $0.00 | x |
| 2014-12-31 | $0.53 | $0.00 | x |
| 2015-12-31 | $2.57 | $0.00 | x |
| 2016-12-31 | $0.01 | $0.00 | x |
| 2017-12-31 | $0.02 | $0.00 | x |
| 2018-12-31 | $0.02 | $0.00 | x |
| 2019-12-31 | $-0.01 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
| 2024-12-31 | $0.00 | $0.00 | x |
| 2025-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Citrine Global Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-290.52%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | -22.82% | 0.00% | 0.00x | 1.12x | $-20.57K |
| 2011 | -220.04% | -75.99% | 0.80x | 3.61x | $-73.81K |
| 2012 | -557.61% | -6003.18% | 0.03x | 3.20x | $-355.41K |
| 2013 | -328.62% | -24931.03% | 0.01x | 1.49x | $-1.49 Million |
| 2014 | -281.60% | -74965.66% | 0.00x | 1.15x | $-4.52 Million |
| 2015 | -145.19% | -26231.19% | 0.01x | 1.00x | $-1.64 Million |
| 2016 | -1626.92% | 0.00% | 0.00x | 3.60x | $-1.87 Million |
| 2017 | -558.83% | 0.00% | 0.00x | 1.69x | $-2.91 Million |
| 2018 | -290.91% | -857.94% | 0.22x | 1.56x | $-2.23 Million |
| 2019 | 0.00% | -1257.00% | 0.58x | 0.00x | $-1.83 Million |
| 2020 | -615.83% | -71992.99% | 0.00x | 2.21x | $-8.78 Million |
| 2021 | 0.00% | 0.00% | -0.05x | 0.00x | $-4.37 Million |
| 2022 | 0.00% | 0.00% | -0.02x | 0.00x | $-2.40 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.86 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.03 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.03 Million |
Industry Comparison
This section compares Citrine Global Corp's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Citrine Global Corp (CTGL) | $-3.88 Million | -22.82% | N/A | $81.97K |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |